DaVita Inc.
HealthcareNYSE:DVA · New York Stock Exchange
+$5.85 today
Vol 0.53M · Avg 0.85M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$13.8B of revenue converted into $781.4M of net income for the selected period. Gross margin is 31.1% and net margin is 5.6%, showing how much revenue survives after costs and taxes. EPS is $9.94, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.6B +6.5% | $12.8B +5.6% | $12.1B +4.6% | $11.6B -0.1% | $11.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $10.0B +15.8% | $8.6B +3.4% | $8.3B +1.3% | $8.2B +3.0% | $8.0B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $3.7B -12.6% | $4.2B +10.4% | $3.8B +12.4% | $3.4B -6.7% | $3.6B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 27.0% -5.9pp | 32.9% +1.4pp | 31.5% +2.2pp | 29.3% -2.1pp | 31.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $1.7B +8.8% | $1.5B +4.4% | $1.5B +8.8% | $1.4B +13.4% | $1.2B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $1.7B -21.3% | $2.1B -4.1% | $2.2B +7.6% | $2.1B +11.5% | $1.8B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $715.3M -1.2% | $723.9M -2.9% | $745.4M +1.8% | $732.6M +7.6% | $680.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $2.6B -3.0% | $2.7B +17.4% | $2.3B +12.9% | $2.1B -17.2% | $2.5B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 19.4% -1.9pp | 21.3% +2.1pp | 19.1% +1.4pp | 17.7% -3.7pp | 21.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $2.0B -3.8% | $2.1B +30.4% | $1.6B +19.7% | $1.3B -25.5% | $1.8B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 14.7% -1.6pp | 16.3% +3.1pp | 13.2% +1.7pp | 11.5% -3.9pp | 15.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $549.7M +16.8% | $470.5M +18.0% | $398.6M +11.6% | $357.0M +25.2% | $285.3M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$663.8M -18.5% | -$560.1M -31.6% | -$425.7M -14.2% | -$372.8M -33.7% | -$278.9M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.3B -12.0% | $1.5B +30.0% | $1.2B +21.8% | $966.3M -36.4% | $1.5B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 9.9% -2.1pp | 11.9% +2.2pp | 9.7% +1.4pp | 8.3% -4.7pp | 13.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $293.1M +4.8% | $279.7M +27.0% | $220.1M +11.1% | $198.1M -35.4% | $306.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | $746.8M -20.2% | $936.3M +35.4% | $691.5M +23.4% | $560.4M -42.7% | $978.5M | $4.9B | $4.8B | $4.7B |
| Net Margin | 5.5% -1.8pp | 7.3% +1.6pp | 5.7% +0.9pp | 4.8% -3.6pp | 8.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $10 -11.8% | $11 +44.6% | $8 +29.6% | $6 -36.8% | $9 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $10 -11.4% | $11 +44.6% | $7 +29.9% | $6 -35.8% | $9 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $86.1M +1.3% | $85.0M -6.4% | $90.8M -2.4% | $93.0M -11.6% | $105.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $88.1M +0.9% | $87.3M -6.3% | $93.2M -2.8% | $95.8M -12.8% | $109.9M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$32.70B
Align Technology, Inc.
NASDAQ:ALGN
$12.50B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.84B
Molina Healthcare, Inc.
NYSE:MOH
$10.43B
Henry Schein, Inc.
NASDAQ:HSIC
$9.30B
Universal Health Services, Inc.
NYSE:UHS
$9.19B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.68B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.71B
AptarGroup, Inc.
NYSE:ATR
$7.53B
Chemed Corporation
NYSE:CHE
$5.57B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does DVA generate?
DaVita Inc. (DVA) reported $13.64B of revenue in fiscal 2025.
Is DVA profitable?
DaVita Inc. (DVA) reported $746.80M of net income, with a net margin of 5.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.